<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-037165</identifier>
<setSpec>0300-8932</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Percutaneous treatment of atrial septal aneurysm</dc:title>
<dc:description xml:lang="en">Among a total number of 203 patients with atrial septaldefects (ASD) or patent foramen ovale (PFO) who were treated by percutaneous closure, we selected 29 (19 with ASD and 10 with PFO) who fulfilled the criteria for atrial septal aneurysm. Eight patients had functional class II orIII dyspnea, and 12 had a history of previous cerebrovascular accident (38%). Seven of the patients with ASD, had a single defect and 12 had multiple defects; 14 received single occluder and 5 patients needed 2 or 3 devices. Follow-up transthoracic ultrasound study at 6 months showed the defect to be successfully closed in all 29 patients. After a mean follow-up time of 31 ± 19 months, all patients were alive and symptom-free. Patients with atrialseptal aneurysm and associated ASD or PFO can be successfully treated with Amplatzer septal occluders</dc:description>
<dc:creator>Suárez de Lezo, José</dc:creator>
<dc:creator>Romero, Miguel</dc:creator>
<dc:creator>Mesa, Dolores</dc:creator>
<dc:creator>Segura, José</dc:creator>
<dc:creator>Medina, Alfonso</dc:creator>
<dc:creator>Pan, Manuel</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">De un total de 203 pacientes con comunicación del septo interauricular (CIA) o foramen oval permeable(FOP) que fueron tratados mediante cierre percutáneo, hemos seleccionado para el estudio a 29 pacientes (19con CIA y 10 con FOP) que cumplieron criterios de aneurisma del septo. Ocho pacientes tenían disnea en grado-funcional II o III y 12 (38%) habían tenido un accidente cerebrovascular (ACV) previo. En pacientes con CIA, 7tuvieron un solo defecto y 12 mostraron perforaciones múltiples; 14 recibieron un solo dispositivo y 5 necesitaron2 o 3. El control ecocardiográfico transtorácico a los 6meses mostró el cierre del defecto en los 29 pacientes. En un tiempo medio de seguimiento de 31 ± 19 meses todos los pacientes estaban libres de síntomas. Los pacientes con aneurisma del septo interauricular yCIA o FOP asociado pueden tratarse con éxito mediante el dispositivo de Amplatz</dc:description>
<dc:source>Rev Esp Cardiol;58(2): 222-226, feb. 2005. ilus</dc:source>
<dc:identifier>ibc-037165</dc:identifier>
<dc:title xml:lang="es">Tratamiento percutáneo de los aneurismas del septo interauricular</dc:title>
<dc:subject>^d35394^s22045</dc:subject>
<dc:subject>^d6474^s22012</dc:subject>
<dc:subject>^d6474^s22067</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d11622</dc:subject>
<dc:subject>^d6474^s29166</dc:subject>
<dc:subject>^d6500^s22045</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d29770</dc:subject>
<dc:subject>^d22780</dc:subject>
<dc:subject>^d23275</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d23623</dc:subject>
<dc:subject>^d6496^s29166</dc:subject>
<dc:subject>^d6496^s22012</dc:subject>
<dc:subject>^d6496^s22067</dc:subject>
<dc:type>article</dc:type>
<dc:date>200502</dc:date>
</metadata>
</record>
</ibecs-document>
